Filing Details

Accession Number:
0001209191-20-054213
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-07 18:40:32
Reporting Period:
2020-10-05
Accepted Time:
2020-10-07 18:40:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1769804 Augmedix Inc. NONE Blank Checks (6770) 833299164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1826030 Jason Krikorian C/O Augmedix, Inc.
1161 Mission Street, Suite 210
San Francisco CA 94103
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-05 3,064,751 $0.00 3,064,751 No 4 A Indirect See footnote
Common Stock Acquisiton 2020-10-05 666,667 $3.00 3,731,418 No 4 P Indirect See footnote
Common Stock Acquisiton 2020-10-05 20,007 $0.00 20,007 No 4 A Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Indirect See footnote
No 4 P Indirect See footnote
No 4 A Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2020-10-05 269,490 $0.00 269,490 $2.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
269,490 2029-09-02 No 4 A Indirect
Footnotes
  1. On October 5, 2020, the Issuer's wholly-owned subsidiary, August Acquisition Corp. ("Acquisition Sub"), merged with and into Augmedix, Inc., a privately held Delaware corporation ("Augmedix"). Pursuant to this transaction (the "Merger"), Augmedix was the surviving corporation and became the Issuer's wholly owned subsidiary. All of the outstanding shares of stock of Augmedix held by accredited investors were converted into shares of the Issuer's common stock. All of the outstanding warrants, options and stock appreciation rights of Augmedix were assumed by the Issuer.
  2. These securities are held of record by DCM VI, L.P. ("DCM VI"). The Reporting Person, a member of our board of directors, is a general partnerat DCM, which is an affiliate of DCM VI. The Reporting Person disclaims beneficial ownership of these securities except to the extent of hispecuniary interest therein, if any.
  3. These securities are held of record by A-Fund, L.P. ("A-Fund"). The Reporting Person, a member of our board of directors, is a general partnerat DCM, which is an affiliate of A-Fund. The Reporting Person disclaims beneficial ownership of these securities except to the extent of hispecuniary interest therein, if any.
  4. The warrants are fully vested and exerciseable.